Skip to content

Assisted Partner Services and HIVST in Western Kenya

Implementing Assisted Partner Services for HIV Testing and Treatment in Western Kenya

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04774835
Enrollment
4941
Registered
2021-03-01
Start date
2021-03-01
Completion date
2022-10-12
Last updated
2022-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiv

Keywords

HIV self-testing, Assisted partner services, Acceptability, Implementation Science

Brief summary

This study includes different designs with Aim 1 being a cluster randomized controlled trial to investigate the use of HIV self-testing (HIVST) as a mode of HIV testing in Western Kenya in addition to the standard of care, assisted partner services (aPS). Aim 2 includes focus group discussions, in-depth interviews, semi-structured interviews, direct observation of facility infrastructure and clinic procedures, and data extraction from facility and county/national databases and expenditure reports to study acceptability, costs, and implementation aspects of HIVST within the aPS framework.

Interventions

DIAGNOSTIC_TESTHIVST

aPS will be offered to sexually active men and women who test HIV seropositive at the study sites by facility staff supported by aPS advisors. Those accepting aPS will be asked to provide names and contact information (phone numbers; home and work addresses) for their sexual partners, and these partners will be contacted, notified anonymously of the HIV exposure, and offered HIV self-testing by HTS counselors working at the facilities. Any partner who tests HIV seropositive will receive assistance linking to care and registering in an HIV comprehensive care clinic. They will also receive aPS so that their partners can be notified and HIV tested. Follow-up of index clients will continue after testing through HTS locations and all partners will be followed to determine HIV testing and treatment outcomes.

DIAGNOSTIC_TESTStandard aPS

aPS will be offered to sexually active men and women who test HIV seropositive at the study sites by facility staff supported by aPS advisors. Those accepting aPS will be asked to provide names and contact information (phone numbers; home and work addresses) for their sexual partners, and these partners will be contacted, notified anonymously of the HIV exposure, and offered HIV testing at their local HTS location by HTS counselors working at the facilities. Any partner who tests HIV seropositive will receive assistance linking to care and registering in an HIV comprehensive care clinic. They will also receive aPS so that their partners can be notified and HIV tested. Follow-up of index clients will continue after testing through HTS locations and all partners will be followed to determine HIV testing and treatment outcomes.

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
Kenyatta National Hospital
CollaboratorOTHER_GOV
University of Nairobi
CollaboratorOTHER
University of Washington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Cluster randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Aim 1: * Men and women * Tests HIV positive and is not in care or on treatment * ≥18 years old * Willing and able to provide informed consent * Able to provide locator information for sexual partners Aim 2: * ≥18 years old * Willing and able to provide informed consent

Exclusion criteria

Aim 1: * Pregnancy * Reports intimate partner violence during last month * \<18 years old Aim 2: • \<18 years old

Design outcomes

Primary

MeasureTime frameDescription
Number of participants testing for the first time1 yearIdentify if there's a difference between standard aPS and aPS+HIVST in the number of participants choosing to get HIV tested for the first time.
Number of newly diagnosed HIV-infected or known positive and not in care1 yearIdentify if there's a difference between standard aPS and aPS+HIVST in the number of participants newly being diagnosed with HIV after participation, or those known to be positive but not currently under care.
Linking a new positive or known positive not in care to a treatment center1 yearIdentify if there's a difference between standard aPS and aPS+HIVST in the number of participants that are linked to care at a treatment center.
Initiating ART, or re-initiating ART if previously lost to follow-up1 yearIdentify if there's a difference between standard aPS and aPS+HIVST in the number of participants that initiate (or re-initiate) ART.

Secondary

MeasureTime frameDescription
Difficulty of using the HIVST kit1 yearUnderstand the ease of using HIV self-testing kits in this population and setting, via a survey question with a 4 point Likert scale ranging from very easy to very hard.
Difficulty of interpreting the HIVST results1 yearUnderstand the readability of HIV self-testing results in this population and setting, via a survey question.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026